About Laronidase
            
            Class: | Enzyme replacement therapy  
Use: | Treatment of mucopolysaccharidosis type I (MPS I), specifically for patients with Hurler syndrome or Hurler-Scheie syndrome  
Adult dose: | 0.58 mg/kg (approximately 1.2 units/kg) administered intravenously every week  
Pediatric dose: | 0.58 mg/kg (approximately 1.2 units/kg) administered intravenously every week; dosing is the same for pediatric patients  
Side effects: | Fever, chills, rash, headache, nausea, vomiting, abdominal pain, and infusion-
         
        
            
                
                
                    
                        Drug Class
                    
                    Enzyme replacement therapy
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of mucopolysaccharidosis type I (MPS I), specifically for patients with Hurler syndrome or Hurler-Scheie syndrome
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; once diluted, use immediately or store at 2°C to 8°C for up to 24 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Genzyme Europe B.V., NETHERLANDS
                    
                    
                    Package Size
                    5ml Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2665.70
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        0.58 mg/kg (approximately 1.2 units/kg) administered intravenously every week
                    
                    
                        Pediatric Dose
                    
                    
                        0.58 mg/kg (approximately 1.2 units/kg) administered intravenously every week; dosing is the same for pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Fever, chills, rash, headache, nausea, vomiting, abdominal pain, and infusion-related reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to Laronidase or any component of the formulation; caution in patients with a history of severe allergic reactions
         
        
        
            
                Important Warnings
            
            Risk of anaphylaxis; monitor patients for hypersensitivity reactions during and after infusion; may cause infusion-related reactions; consider premedication with antihistamines and/or antipyretics for patients with a history of reactions
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.